Amy E. Ratliff

709 total citations
19 papers, 458 citations indexed

About

Amy E. Ratliff is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Amy E. Ratliff has authored 19 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Microbiology and 4 papers in Infectious Diseases. Recurrent topics in Amy E. Ratliff's work include Microbial infections and disease research (9 papers), Pneumonia and Respiratory Infections (7 papers) and Respiratory viral infections research (6 papers). Amy E. Ratliff is often cited by papers focused on Microbial infections and disease research (9 papers), Pneumonia and Respiratory Infections (7 papers) and Respiratory viral infections research (6 papers). Amy E. Ratliff collaborates with scholars based in United States. Amy E. Ratliff's co-authors include Ken B. Waites, Donna M. Crabb, Li Xiao, T. Prescott Atkinson, Lynn B. Duffy, Rangaraj Selvarangan, Xiaotian Zheng, William M. Geisler, Carlos A. Estrada and Robert M. Centor and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Amy E. Ratliff

18 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Ratliff United States 12 290 234 105 103 77 19 458
Zafer Ecevit Türkiye 10 218 0.8× 175 0.7× 61 0.6× 53 0.5× 24 0.3× 29 327
Naoki Tsumura Japan 12 218 0.8× 94 0.4× 83 0.8× 46 0.4× 60 0.8× 35 375
Stan Block United States 8 395 1.4× 224 1.0× 54 0.5× 62 0.6× 24 0.3× 12 543
Marcus Pond United Kingdom 11 192 0.7× 251 1.1× 125 1.2× 57 0.6× 117 1.5× 25 458
G Falck Sweden 9 181 0.6× 168 0.7× 47 0.4× 75 0.7× 38 0.5× 19 323
B. Maraha Netherlands 11 157 0.5× 50 0.2× 105 1.0× 38 0.4× 52 0.7× 21 334
Peter K. Cummings United States 6 293 1.0× 446 1.9× 34 0.3× 65 0.6× 103 1.3× 7 572
Amalia Franco-Buff United States 6 287 1.0× 242 1.0× 63 0.6× 113 1.1× 45 0.6× 8 459
Satoko Ogita Japan 12 496 1.7× 312 1.3× 46 0.4× 35 0.3× 28 0.4× 31 597
Paola Nardini Italy 13 155 0.5× 211 0.9× 29 0.3× 33 0.3× 80 1.0× 26 460

Countries citing papers authored by Amy E. Ratliff

Since Specialization
Citations

This map shows the geographic impact of Amy E. Ratliff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Ratliff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Ratliff more than expected).

Fields of papers citing papers by Amy E. Ratliff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Ratliff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Ratliff. The network helps show where Amy E. Ratliff may publish in the future.

Co-authorship network of co-authors of Amy E. Ratliff

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Ratliff. A scholar is included among the top collaborators of Amy E. Ratliff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Ratliff. Amy E. Ratliff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Crabb, Donna M., et al.. (2025). Antimicrobial susceptibility and genetic mechanisms of resistance of Ureaplasma isolates in North America between 2012 and 2023. Antimicrobial Agents and Chemotherapy. 69(6). e0186824–e0186824.
2.
Waites, Ken B., Donna M. Crabb, Amy E. Ratliff, et al.. (2023). Latest Advances in Laboratory Detection of Mycoplasma genitalium. Journal of Clinical Microbiology. 61(3). e0079021–e0079021. 22 indexed citations
4.
Xiao, Li, Amy E. Ratliff, Donna M. Crabb, et al.. (2020). Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018. Journal of Clinical Microbiology. 58(10). 34 indexed citations
5.
Eschenauer, Gregory, Li Xiao, Ken B. Waites, et al.. (2020). Macrolide‐resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?. Transplant Infectious Disease. 22(5). e13318–e13318. 3 indexed citations
6.
Glaser, Allison, William M. Geisler, Amy E. Ratliff, et al.. (2019). Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline. International Journal of STD & AIDS. 30(5). 512–514. 13 indexed citations
7.
Olson, Kristin M., Amy E. Ratliff, Li Xiao, et al.. (2019). Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis Infection. Sexually Transmitted Diseases. 46(10). e101–e104. 11 indexed citations
8.
Leal, Sixto M., et al.. (2019). Evaluation of the ELITe InGenius PCR Platform for Detection of Mycoplasma pneumoniae. Journal of Clinical Microbiology. 57(6). 5 indexed citations
9.
Waites, Ken B., Amy E. Ratliff, Donna M. Crabb, et al.. (2019). Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. Journal of Clinical Microbiology. 57(11). 66 indexed citations
10.
Xiao, Li, Ken B. Waites, Hong Wang, et al.. (2018). Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens. Diagnostic Microbiology and Infectious Disease. 91(2). 123–125. 12 indexed citations
11.
Atkinson, T. Prescott, Robert M. Centor, Li Xiao, et al.. (2018). Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity. PLoS ONE. 13(1). e0189423–e0189423. 18 indexed citations
12.
Fernandez, Ramiro, Amy E. Ratliff, Donna M. Crabb, Ken B. Waites, & Ankit Bharat. (2017). Ureaplasma Transmitted From Donor Lungs Is Pathogenic After Lung Transplantation. The Annals of Thoracic Surgery. 103(2). 670–671. 42 indexed citations
13.
Novosad, Shannon, Sridhar V. Basavaraju, Pallavi Annambhotla, et al.. (2017). Mycoplasma hominis Infections Transmitted Through Amniotic Tissue Product. Clinical Infectious Diseases. 65(7). 1152–1158. 3 indexed citations
14.
Xiao, Li, Donna M. Crabb, Amy E. Ratliff, et al.. (2016). Shaken or stirred?: Comparison of methods for dispersion of Mycoplasma pneumoniae aggregates for persistence in vivo. Journal of Microbiological Methods. 132. 56–62. 7 indexed citations
15.
Oldach, David, Hristo Metev, Analía Mykietiuk, et al.. (2015). Characterization of Mycoplasma pneumoniae Infection and Outcomes in the SOLITAIRE-Oral, Global Phase 3 Clinical Trial for Solithromycin. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations
16.
Benitez, Alvaro J., Amy E. Ratliff, Donna M. Crabb, et al.. (2015). Specificity and Strain-Typing Capabilities of Nanorod Array-Surface Enhanced Raman Spectroscopy for Mycoplasma pneumoniae Detection. PLoS ONE. 10(6). e0131831–e0131831. 19 indexed citations
17.
Zheng, Xiaotian, Stella Lee, Rangaraj Selvarangan, et al.. (2015). Macrolide-ResistantMycoplasma pneumoniae, United States1. Emerging infectious diseases. 21(8). 1470–1472. 84 indexed citations
18.
Centor, Robert M., T. Prescott Atkinson, Amy E. Ratliff, et al.. (2015). The Clinical Presentation of Fusobacterium-Positive and Streptococcal-Positive Pharyngitis in a University Health Clinic. Annals of Internal Medicine. 162(4). 241–247. 76 indexed citations
19.
Ratliff, Amy E., Lynn B. Duffy, & Ken B. Waites. (2014). Comparison of the illumi gene Mycoplasma DNA Amplification Assay and Culture for Detection of Mycoplasma pneumoniae. Journal of Clinical Microbiology. 52(4). 1060–1063. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026